Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TBPH Theravance Biopharma Inc.

未开盘 05-01 16:00:00 EDT

8.84

+0.40

+4.74%

盘后8.84

+0.000.00%

16:05 EDT

最高8.98	最低8.40	成交量205.68万
今开8.44	昨收8.44	日振幅6.87%
总市值4.29亿	流通市值1.41亿	总股本4,856万
成交额1,803万	换手率12.86%	流通股本1,600万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TBPH","market":"US","secType":"STK","nameCN":"Theravance Biopharma Inc.","latestPrice":8.84,"timestamp":1714593600000,"preClose":8.44,"halted":0,"volume":2056759,"hourTrading":{"tag":"盘后","latestPrice":8.84,"preClose":8.84,"latestTime":"16:05 EDT","volume":8183,"amount":72347.52,"timestamp":1714593954666},"delay":0,"floatShares":15995372,"shares":48559955,"eps":-0.99801,"marketStatus":"未开盘","marketStatusCode":0,"change":0.4,"latestTime":"05-01 16:00:00 EDT","open":8.44,"high":8.98,"low":8.4,"amount":18026026.165833,"amplitude":0.06872,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.99801,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714636800000},"adr":0,"listingDate":1400212800000,"adjPreClose":8.44,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":8.84,"preClose":8.84,"latestTime":"16:05 EDT","volume":8183,"amount":72347.52,"timestamp":1714593954666},"volumeRatio":6.388399},"requestUrl":"/m/hq/s/TBPH","defaultTab":"news","newsList":[{"id":"2432588024","title":"Theravance Biopharma, Inc.盘中异动 急速下跌5.01%报8.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432588024","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432588024?lang=zh_cn&edition=full","pubTime":"2024-05-01 02:51","pubTimestamp":1714503070,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日02时51分，Theravance Biopharma, Inc.股票出现异动，股价快速下挫5.01%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Eliem Therapeutics, Inc涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1522.35%、237.13%、30.27%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Eliem Therapeutics, Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为60.76%、55.38%、48.00%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010251107a57ca44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010251107a57ca44&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426780727","title":"Theravance Biopharma, Inc.盘中异动 早盘大幅上涨6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426780727","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426780727?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:31","pubTimestamp":1712928668,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时31分，Theravance Biopharma, Inc.股票出现异动，股价大幅上涨6.05%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。该信息摘要如下：Theravance Biopharma获BTIG首次覆盖，给予买入评级, 目标价21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213109876f4540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213109876f4540&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426674932","title":"Theravance Biopharma, Inc.盘中异动 急速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426674932","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426674932?lang=zh_cn&edition=full","pubTime":"2024-04-12 00:28","pubTimestamp":1712852911,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日00时28分，Theravance Biopharma, Inc.股票出现异动，股价急速下跌5.14%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Candel Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为710.63%、537.18%、502.36%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为50.92%、46.31%、40.90%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041200283187e7fad8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041200283187e7fad8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419601716","title":"Theravance Biopharma, Inc.盘中异动 早盘急速上涨5.17%报9.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419601716","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419601716?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:30","pubTimestamp":1710423004,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时30分，Theravance Biopharma, Inc.股票出现异动，股价急速拉升5.17%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，冠科美博、Novabay Pharmaceuticals, Inc.、Theravance Biopharma, Inc.涨幅较大，Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.、First Wave Biopharma, Inc.较为活跃，换手率分别为114.21%、53.33%、50.03%，振幅较大的相关个股有Renovorx, Inc.、Actinium Pharmaceuticals, Inc. 、Novabay Pharmaceuticals, Inc.，振幅分别为7.23%、0.45%、0.07%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213004791a7b33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213004791a7b33&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417742289","title":"Theravance Biopharma, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417742289","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417742289?lang=zh_cn&edition=full","pubTime":"2024-03-06 04:32","pubTimestamp":1709670731,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日04时32分，Theravance Biopharma, Inc.股票出现异动，股价急速下挫5.00%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.64%。其相关个股中，万春医药、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为373.92%、232.06%、210.79%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Revelation Biosciences Inc C/Wts 10/01/2027 、Ocean Biomedical, Inc.，振幅分别为101.72%、98.45%、89.22%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604321187e76279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604321187e76279&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416162320","title":"Theravance Biopharma, Inc.2023财年实现净利润-55.19百万美元，同比增加40.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416162320","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416162320?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:24","pubTimestamp":1709310289,"startTime":"0","endTime":"0","summary":"12月31日，Theravance Biopharma, Inc.公布财报，公告显示公司2023财年净利润为-55.19百万美元，同比增加40.54%；其中营业收入为57.42百万美元，同比增加11.82%，每股基本收益为-1.00美元。机构评级：截至2023年12月31日，当前有3家机构对Theravance Biopharma, Inc.目标价做出预测，其中目标均价为13.67美元，其中最低目标价为10.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200245287d85e0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200245287d85e0f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414013228","title":"Theravance Biopharma Inc盘中异动 早盘急速拉升5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414013228","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414013228?lang=zh_cn&edition=full","pubTime":"2024-02-27 23:24","pubTimestamp":1709047481,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日23时24分，Theravance Biopharma Inc股票出现波动，股价大幅拉升5.63%。Theravance Biopharma Inc股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Celularity Inc C/Wts 16/07/2026 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为343.98%、156.25%、32.73%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Janux Therapeutics Inc、Viking Therapeutics Inc，振幅分别为86.60%、57.95%、50.96%。Theravance Biopharma Inc公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272324427a475594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272324427a475594&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2401639435","title":"Theravance Biopharma Inc股价重挫10.16% 市值跌5236.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2401639435","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401639435?lang=zh_cn&edition=full","pubTime":"2024-01-05 22:34","pubTimestamp":1704465242,"startTime":"0","endTime":"0","summary":"北京时间2024年01月05日22时34分，Theravance Biopharma Inc股票出现异动，股价急速下跌10.16%。截至发稿，该股报10.35美元/股，成交量6.3504万股，换手率0.13%，振幅3.91%。Theravance Biopharma Inc股票所在的生物技术行业中，整体跌幅为0.55%。Theravance Biopharma Inc公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401052234028798343b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401052234028798343b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2383723704","title":"Theravance Biopharma Inc2023财年第三财季实现净利润-8.95百万美元，同比增加44.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2383723704","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383723704?lang=zh_cn&edition=full","pubTime":"2023-11-13 00:29","pubTimestamp":1699806544,"startTime":"0","endTime":"0","summary":"9月30日，Theravance Biopharma Inc公布财报，公告显示公司2023财年第三财季净利润为-8.95百万美元，同比增加44.13%；其中营业收入为15.69百万美元，同比增加26.02%，每股基本收益为-0.17美元。机构评级：截至2023年9月30日，当前有4家机构对Theravance Biopharma Inc目标价做出预测，其中目标均价为14.50美元，其中最低目标价为10.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113002911840bf014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113002911840bf014&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2381836662","title":"Theravance Biopharma Inc盘中异动 早盘急速拉升5.34%报10.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2381836662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2381836662?lang=zh_cn&edition=full","pubTime":"2023-11-08 22:30","pubTimestamp":1699453828,"startTime":"0","endTime":"0","summary":"北京时间2023年11月08日22时30分，Theravance Biopharma Inc股票出现波动，股价急速拉升5.34%。截至发稿，该股报10.25美元/股，成交量4799股，换手率0.01%，振幅0.00%。Theravance Biopharma Inc股票所在的生物技术行业中，整体涨幅为0.10%。Theravance Biopharma Inc公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231108223028806a9d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231108223028806a9d33&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theravance.com","stockEarnings":[{"period":"1week","weight":-0.036},{"period":"1month","weight":-0.021},{"period":"3month","weight":-0.0349},{"period":"6month","weight":-0.1025},{"period":"1year","weight":-0.1927},{"period":"ytd","weight":-0.2135}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Theravance Biopharma, Inc.，于2013年7月注册为开曼群岛豁免股份有限公司。该公司是一家生物制药公司，主要专注于药物的发现、开发和商业化。该公司的核心宗旨是创造能够改变人们生活的药物。该公司利用数十年的专业知识，开发了FDA批准的YUPELRI（revefenacin）吸入溶液，用于慢性阻塞性肺病患者的维持治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.024681},{"month":2,"riseRate":0.3,"avgChangeRate":0.011183},{"month":3,"riseRate":0.4,"avgChangeRate":0.013288},{"month":4,"riseRate":0.5,"avgChangeRate":0.034332},{"month":5,"riseRate":0.4,"avgChangeRate":-0.067574},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.049452},{"month":7,"riseRate":0.3,"avgChangeRate":-0.014919},{"month":8,"riseRate":0.7,"avgChangeRate":0.017437},{"month":9,"riseRate":0.4,"avgChangeRate":-0.039227},{"month":10,"riseRate":0.4,"avgChangeRate":-0.033295},{"month":11,"riseRate":0.7,"avgChangeRate":0.084893},{"month":12,"riseRate":0.6,"avgChangeRate":0.056025}],"exchange":"NASDAQ","name":"Theravance Biopharma Inc.","nameEN":"Theravance Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Theravance Biopharma Inc.,TBPH,Theravance Biopharma Inc.股票,Theravance Biopharma Inc.股票老虎,Theravance Biopharma Inc.股票老虎国际,Theravance Biopharma Inc.行情,Theravance Biopharma Inc.股票行情,Theravance Biopharma Inc.股价,Theravance Biopharma Inc.股市,Theravance Biopharma Inc.股票价格,Theravance Biopharma Inc.股票交易,Theravance Biopharma Inc.股票购买,Theravance Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况